Functional analysis of Csk and CHK kinases in breast cancer cells. (Q40793615)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11445575%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Functional analysis of Csk and CHK kinases in breast cancer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11445575%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author

Hava Karsenty Avraham

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11445575%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

C Bougeret

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11445575%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

S Jiang

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11445575%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

I Keydar

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11445575%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

language of work or name

English

0 references

publication date

9 July 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11445575%20AND%20SRC:MED&resulttype=core&format=json

Journal of Biological Chemistry

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11445575%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

276

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11445575%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11445575%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

33711-33720

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11445575%20AND%20SRC:MED&resulttype=core&format=json

Recent advances in breast cancer biology

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

Signal transduction in mammary tumorigenesis: a transgenic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

Role of HER2 gene overexpression in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

The erbB-2 mitogenic signaling pathway: tyrosine phosphorylation of phospholipase C-gamma and GTPase-activating protein does not correlate with erbB-2 mitogenic potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

Cellular functions regulated by Src family kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

Ctk: a protein-tyrosine kinase related to Csk that defines an enzyme family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

Identification and characterization of Batk, a predominantly brain-specific non-receptor protein tyrosine kinase related to Csk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

The Csk-like proteins Lsk, Hyl, and Matk represent the same Csk homologous kinase (Chk) and are regulated by stem cell factor in the megakaryoblastic cell line MO7e

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

Chk, a Csk family tyrosine protein kinase, exhibits Csk-like activity in fibroblasts, but not in an antigen-specific T-cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

Structural and functional studies of the intracellular tyrosine kinase MATK gene and its translated product

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

Translocation of the Csk homologous kinase (Chk/Hyl) controls activity of CD36-anchored Lyn tyrosine kinase in thrombin-stimulated platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

Overexpression of C-terminal Src kinase homologous kinase suppresses activation of Lyn tyrosine kinase required for VLA5-mediated Dami cell spreading

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

CHK down-regulates SCF/KL-activated Lyn kinase activity in Mo7e megakaryocytic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

IL-4 and IL-13 induce Lsk, a Csk-like tyrosine kinase, in human monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

The MATK tyrosine kinase interacts in a specific and SH2-dependent manner with c-Kit

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

Direct association of Csk homologous kinase (CHK) with the diphosphorylated site Tyr568/570 of the activated c-KIT in megakaryocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

The Csk homologous kinase associates with TrkA receptors and is involved in neurite outgrowth of PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

The Csk homologous kinase, Chk, binds tyrosine phosphorylated paxillin in human blastic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

Association of csk-homologous kinase (CHK) (formerly MATK) with HER-2/ErbB-2 in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

Csk homologous kinase, a novel signaling molecule, directly associates with the activated ErbB-2 receptor in breast cancer cells and inhibits their proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

Expression in rat fibroblasts of a human transforming growth factor-alpha cDNA results in transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

ErbB2 is necessary for induction of carcinoma cell invasion by ErbB family receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

Src and the control of cell division

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

Requirement for Src family protein tyrosine kinases in G2 for fibroblast cell division

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

RAFTK/Pyk2 tyrosine kinase mediates the association of p190 RhoGAP with RasGAP and is involved in breast cancer cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

Signaling--2000 and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

Anticancer drug targets: growth factors and growth factor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

Tyrosine kinase inhibitors in preclinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

The ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

Protein tyrosine kinase inhibitors as novel therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104209200

21 January 2018

Identifiers

DOI

10.1074/JBC.M104209200

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11445575%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11445575%20AND%20SRC:MED&resulttype=core&format=json